出海机会来了!欧美药企紧急寻找NLRP3创新药产品,IND-enabling阶段优先考虑,暂不考虑细胞疗法、基因疗法。希望产品具有明显的差异化优势!请感兴趣的公司立即联系药时代BD团队BD@drugtimes.cn正文共:1900字预计阅读时间:5分钟“女王已死,新王当立”,这句最早可追溯至15世纪的法国谚语,用在当下眼科药物市场,也挺合适。从雷珠单抗,到阿柏西普,再到如今的法瑞西单抗(...
Source Link出海机会来了!欧美药企紧急寻找NLRP3创新药产品,IND-enabling阶段优先考虑,暂不考虑细胞疗法、基因疗法。希望产品具有明显的差异化优势!请感兴趣的公司立即联系药时代BD团队BD@drugtimes.cn正文共:1900字预计阅读时间:5分钟“女王已死,新王当立”,这句最早可追溯至15世纪的法国谚语,用在当下眼科药物市场,也挺合适。从雷珠单抗,到阿柏西普,再到如今的法瑞西单抗(...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.